The symptom burden and quality of life in cancer patients in the Gaza strip, Palestine: a cross-sectional study

Y ElMokhallalati, E Alaloul, M Shatat, T Shneewra… - PLoS …, 2022 - journals.plos.org
Objectives Cancer is the second leading cause of death in the Gaza Strip, Palestine, but
there is an absence of evidence systematically assessing symptom burden and quality of life …

Do patients benefit from a trial of corticosteroids at the end of life?

S Yennurajalingam, E Bruera - Current treatment options in oncology, 2022 - Springer
Opinion statement Patients with advanced cancer in the last 6 months of their lives have a
higher frequency of distressing and debilitating physical and psychosocial symptoms such …

Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve …

JB Permuth, MA Park, DT Chen, T Basinski… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction Cancer-associated cachexia (CC) is a progressive syndrome characterized by
unintentional weight loss, muscle atrophy, fatigue, and poor outcomes that affects most …

The prevalence and risk of symptom and function clusters in colorectal cancer survivors

AL Potosky, KD Graves, L Lin, W Pan… - Journal of Cancer …, 2022 - Springer
Purpose Our purpose was to describe the prevalence and predictors of symptom and
function clusters in a diverse cohort of colorectal cancer survivors. Methods We used data …

End-of-Life Symptom Burden among Patients with Cancer Who Were Provided Medical Assistance in Dying (MAID): A Longitudinal Propensity-Score-Matched Cohort …

KB Russell, C Forbes, S Qi, C Link, L Watson, A Deiure… - Cancers, 2024 - mdpi.com
Simple Summary Cancer is the most common medical condition among Canadians who
receive Medical Assistance in Dying (MAID). We aimed to evaluate if people who choose …

Prognostic Impact of Patient-Reported Symptoms in Multiple Myeloma

N Abdallah, A Bohra, A Mammadzadeh… - Blood …, 2024 - ashpublications.org
Patient-reported outcomes (PROs) are associated with treatment outcomes in multiple
myeloma (MM) in the clinical trial setting. However, most PRO tools are time consuming …

The effect of burdensome symptoms and functional status on quality of life among older patients with cancer: A correlational study

EH Othman, M AlOsta, HM Abu-Snieneh… - European Journal of …, 2023 - Elsevier
Purpose The current study aimed to assess the effect of burdensome symptoms and
functional status on QoL among Jordanian older patients with cancer presenting to …

Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast Cancer

CE Mosher, S Lee, EL Addington, S Park… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Fatigue is a highly prevalent and disabling symptom for patients with metastatic
breast cancer (MBC). Evidence-based interventions for managing fatigue in advanced …

Effectiveness of a palliative care education program for caregivers of cancer patients receiving chemotherapy in Port Said City: A pre-post quasi-experimental study

AM Ibrahim, SF Elnaghy, GMA Elmatty… - Palliative & Supportive …, 2024 - cambridge.org
BackgroundEmphasizing the pivotal role of caregivers in the cancer care continuum, a
program designed to educate caregivers of cancer patients undergoing chemotherapy …

Distinct profiles of morning and evening fatigue co-occurrence in patients during chemotherapy

F Wright, BA Cooper, SM Paul, MJ Hammer… - Nursing …, 2023 - journals.lww.com
Background Morning and evening fatigue are distinct and distressing symptoms
experienced during chemotherapy that demonstrate a large amount of interindividual …